Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
Brian O Mahony, CEO of Irish Haemophilia Society, posted in appreciation of Michael Makris on X:
”Professor Michael Makris giving his view on bleeding disorders treatment and comprehensive care in year 2035 at HABIT Summit 2025 in Osaka, Japan.”
While most of us are still figuring out how to schedule next week’s clinic, Professor Michael Makris is already living in 2035.
At the HABIT Summit 2025 held in Osaka, Japan, Professor Makris, a leading voice in hematology, delivered an insightful presentation on the projected state of bleeding disorders care in the year 2035.
With decades of experience in clinical practice and policy, he offered a forward-looking perspective on how treatment, patient management, and comprehensive care models are expected to evolve over the next decade.
Read Hemostasis Today, to not miss out on important in the field of thrombosis and hemostasis.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly